Literature DB >> 12077061

Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.

H Mertz1.   

Abstract

Several features of the irritable bowel syndrome (IBS) suggest involvement of the emotional limbic system in the brain. Abnormalities which upregulate afferent (sensory) signal intensity anywhere in this system, from the gastrointestinal tract to the brain, could induce hypersensitivity, leading to the pain and discomfort that characterise IBS and other functional disorders. Functional gastrointestinal disorders are likely to be heterogeneous given the complexity of the afferent system, and a number of different perturbations are possible. Intestinal hypersensitivity to pain and discomfort and associated reflex alterations in motility might explain the symptoms of functional bowel diseases.

Entities:  

Mesh:

Year:  2002        PMID: 12077061      PMCID: PMC1867728          DOI: 10.1136/gut.51.suppl_1.i29

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  43 in total

1.  Corticotropin-releasing factor directly mediates colonic responses to stress.

Authors:  C L Williams; J M Peterson; R G Villar; T F Burks
Journal:  Am J Physiol       Date:  1987-10

2.  Genetic influences on brain stimulation-produced analgesia in mice. I. Correlation with stress-induced analgesia.

Authors:  P Marek; R Yirmiya; I Panocka; J C Liebeskind
Journal:  Brain Res       Date:  1989-06-05       Impact factor: 3.252

3.  Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception.

Authors:  W Jänig; J F Morrison
Journal:  Prog Brain Res       Date:  1986       Impact factor: 2.453

4.  Dysmotility of the small intestine in irritable bowel syndrome.

Authors:  J E Kellow; S F Phillips; L J Miller; A R Zinsmeister
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Level of chronic life stress predicts clinical outcome in irritable bowel syndrome.

Authors:  E J Bennett; C C Tennant; C Piesse; C A Badcock; J E Kellow
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

Authors:  P Welgan; H Meshkinpour; M Beeler
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

7.  Origin of chronic right upper quadrant pain.

Authors:  J G Kingham; A M Dawson
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

8.  Tolerance for rectosigmoid distention in irritable bowel syndrome.

Authors:  W E Whitehead; B Holtkotter; P Enck; R Hoelzl; K D Holmes; J Anthony; H S Shabsin; M M Schuster
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

9.  Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples.

Authors:  W E Whitehead; L Bosmajian; A B Zonderman; P T Costa; M M Schuster
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  20 in total

Review 1.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

2.  Gastric distension causes changes in heart rate and arterial blood pressure by affecting the crosstalk between vagal and splanchnic systems in anesthetised rats.

Authors:  Maurizio Sabbatini; Elena Grossini; Claudio Molinari; David A S G Mary; Giovanni Vacca; Mario Cannas
Journal:  Exp Brain Res       Date:  2017-01-13       Impact factor: 1.972

3.  Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colon.

Authors:  F Bellucci; L Buéno; R Bugianesi; A Crea; V D'Aranno; S Meini; P Santicioli; M Tramontana; C A Maggi
Journal:  Br J Pharmacol       Date:  2016-03-07       Impact factor: 8.739

4.  Tegaserod inhibits noxious rectal distention induced responses and limbic system c-Fos expression in rats with visceral hypersensitivity.

Authors:  Hong-Mei Jiao; Peng-Yan Xie
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

5.  The pattern of c-Fos immunoreactivity in the hindbrain of the rat following stomach distension.

Authors:  M Sabbatini; C Molinari; E Grossini; D A S G Mary; G Vacca; M Cannas
Journal:  Exp Brain Res       Date:  2004-04-20       Impact factor: 1.972

6.  Gabapentin Use in the Neonatal Intensive Care Unit.

Authors:  Laura Edwards; Stephen DeMeo; Chi D Hornik; C Michael Cotten; P Brian Smith; Carolyn Pizoli; Julie M Hauer; Margarita Bidegain
Journal:  J Pediatr       Date:  2015-11-11       Impact factor: 4.406

Review 7.  Current insights into the pathophysiology of irritable bowel syndrome.

Authors:  Ines Schwetz; Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 8.  Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response?

Authors:  Felipe Fregni; Alvaro Pascual-Leone; Steven D Freedman
Journal:  Pancreatology       Date:  2007-09-25       Impact factor: 3.996

Review 9.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

Review 10.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.